ANI Pharmaceuticals Inc
ANIP
|
|
| |
|
| Trading Volume | 1,846 |
|
|
70.08 - 48.72 |
| Market Cap Full | $ 1.5B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 0.2% | 25.3% | -1.3% | -35.6% |
| Q2 | - | -7.1% | 35.5% | 0% |
| Q3 | - | -4.9% | 7.9% | 8.3% |
| Q4 | - | -5.2% | -3% | 25.2% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 1.2 | 21.2 | 2.1 | -5.1 | -1 | -2.8 | 4.1 | -4.9 | - | - | - | -3.3 |
| 2023 | |||||||||||
| 11.2 | -6.5 | -5.1 | -5 | 19.7 | 19.3 | -2.4 | 22.5 | -9.8 | 6.3 | -19.3 | 10.7 |
| 2022 | |||||||||||
| -12.3 | -9.4 | -19 | -0.5 | 2.5 | -1.9 | 14.1 | 4.3 | -8.9 | 20.1 | 8.7 | -4.1 |
| 2021 | |||||||||||
| -1.7 | 2 | 24.2 | -7.9 | 3.2 | 2 | -3.2 | -10.6 | 8.2 | 13.9 | 10.1 | 12 |
| 2020 | |||||||||||
| 1.8 | -23.6 | -14.1 | -1.8 | -22.4 | 4.1 | -8.4 | 5.9 | -10 | -9.6 | 16 | -1.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.1 | -1.3 | 0 | -0.6 |
| Q2 | 0.3 | -0.9 | -1.2 | -1 |
| Q3 | 0.5 | -0.6 | -0.4 | 0 |
| Q4 | 0 | -0.3 | -1.9 | -0.3 |
| A | 0.8 | -3.1 | -3.4 | -1.9 |